Targeting EGFR in nasopharyngeal carcinoma

Autor: Efthymios, Kyrodimos, Aristeidis, Chrysovergis, Nicholas, Mastronikolis, Evangelos, Tsiambas, Vasileios, Ragos, Dimitrios, Roukas, Panagiotis, Fotiades, Vasileios, Papanikolaou
Rok vydání: 2021
Předmět:
Zdroj: Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 26(3)
ISSN: 2241-6293
Popis: Nasopharyngeal carcinoma (NPC) represents a specific, aggressive pathological entity included in the Head and Neck Carcinoma (HNC) family of malignancies. NPC is derived from the nasopharyngeal epithelia expressing a high invasive and metastatic potential affecting negatively patients' prognosis due to poor survival rates. Concerning pathogenetic factors implicated in its rise and progression, Epstein-Barr virus (EBV) latent but persistent infection is considered the main one. Novel therapeutic strategies are based on targeting specific molecules such as epidermal growth factor receptor (EGFR) by applying anti-EGFR monoclonal antibodies (mABs) that block their natural ligands interrupting also aberrant signal transduction to nucleus. Anti-EGFR therapies combined or not with radiotherapy seem to be a very promising tool in handling the corresponding patients with NPC that demonstrate specific genetic signatures. In the current article, we focused on presenting EGFR expression in NPC combined with novel anti-EGFR agents.
Databáze: OpenAIRE